First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Virginia Commonwealth University
M.D. Anderson Cancer Center
Poniard Pharmaceuticals